Tucidinostat plus pediatric-inspired chemotherapy for newly diagnosed adult ETP-ALL/LBL: a single-arm, phase 2 trial

Abstract Early T-cell precursor lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) is a distinct subtype of T-ALL/LBL, characterized by a poor response to initial chemotherapy, a high relapse rate, and an inferior outcome. The treatment options for ETP-ALL/LBL are currently limited, and there are no repo...

Full description

Bibliographic Details

Published in:	Journal of Hematology & Oncology
Main Authors:	Jieping Lin, Zicong Huang, Zihong Cai, Jia Li, Zhen Li, Chenhao Ding, Zhixiang Wang, Xiaofang Li, Xuan Zhou, Bailin He, Wenhao Zhong, Li Xuan, Qifa Liu, Yang Xu, Hongsheng Zhou
Format:	Article
Language:	English
Published:	BMC 2024-10-01
Subjects:	Early T-cell precursor lymphoblastic leukemia/lymphoma Histone deacetylase inhibitor Tucidinostat
Online Access:	https://doi.org/10.1186/s13045-024-01624-8